Underlying FY results were broadly as expected, with the continuing operations comprised of the Energy and Medical (E&M) division post the £65.0m disposal of its aerospace business. The group is expected to return £28m to shareholders shortly. Outlook prospects are encouraging having recently had some strong new contract wins (e.g. EDF, Bruker and Rapiscan). The Sellafield contract will start to kick in through 2018. The underlying oil and gas market remains in the doldrums bu
27 Sep 2016
FY results – at the fulcrum of change
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
FY results – at the fulcrum of change
Avingtrans plc (AVG:LON) | 390 0 0.0% | Mkt Cap: 129.1m
- Published:
27 Sep 2016 -
Author:
David Buxton -
Pages:
12
Underlying FY results were broadly as expected, with the continuing operations comprised of the Energy and Medical (E&M) division post the £65.0m disposal of its aerospace business. The group is expected to return £28m to shareholders shortly. Outlook prospects are encouraging having recently had some strong new contract wins (e.g. EDF, Bruker and Rapiscan). The Sellafield contract will start to kick in through 2018. The underlying oil and gas market remains in the doldrums bu